Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation of the Success Rate of Immediately Loaded Implants

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2013 by University Hospital, Ghent
Sponsor:
Information provided by (Responsible Party):
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00314015
First received: April 11, 2006
Last updated: January 29, 2013
Last verified: January 2013
  Purpose

Evaluation of the success rate of immediately loaded implants based on:

  • condition of the gingiva
  • stability of the implants
  • evaluation of the RXs
  • questionnaires

Condition Intervention
Dental Implants
Procedure: Evaluation of the success rate of implants
Procedure: Questionnaires

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Evaluation of the Success Rate of Immediately Loaded Implants

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Success of implants [ Time Frame: Continuous follow-up ] [ Designated as safety issue: No ]
  • Prothetic complications [ Time Frame: Continuous follow-up ] [ Designated as safety issue: No ]
  • Opinion of the patient [ Time Frame: Continuous follow-up ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: January 2007
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Patients with immediately loaded implants. Procedure: Evaluation of the success rate of implants
Evaluation of the success rate of implants will be followed.
Procedure: Questionnaires
Questionnaires will be used

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients with immediately loaded implants
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00314015

Contacts
Contact: Hugo De Bruyn, MD, PhD + 32 9 332.40.18 hugo.debruyn@UGent.be

Locations
Belgium
University Hospital Ghent Recruiting
Ghent, Belgium, 9000
Contact: Hugo De Bruyn, MD, PhD    + 32 9 332.40.18    hugo.debruyn@UGent.be   
Principal Investigator: Hugo De Bruyn, MD, PhD         
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Hugo De Bruyn, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

Responsible Party: University Hospital, Ghent
ClinicalTrials.gov Identifier: NCT00314015     History of Changes
Other Study ID Numbers: 2006/121
Study First Received: April 11, 2006
Last Updated: January 29, 2013
Health Authority: Belgium: Institutional Review Board

ClinicalTrials.gov processed this record on November 25, 2014